Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Dig Dis Sci. 2017 Sep 6;62(10):2704–2712. doi: 10.1007/s10620-017-4714-8

Table 1.

Demographic and clinical factors among 4,874 HCV-infected patients with survey data

Characteristic n (%)

Study site
 Portland, OR 1665 (34)
 Honolulu, HI 366 (8)
 Detroit, MI 1710 (35)
 Danville, PA 1133 (23)

Age group
 18–34 years 221 (5)
 35–54 years 904 (19)
 55–64 years 2332 (48)
 ≥65 years 1417 (29)

Male 2734 (56)

Race/ethnicity
 Black 929 (19)
 White 3540 (73)
 Asian/Other 405 (8)
 Hispanic 225 (4.6)

Privately insured 2677 (55)

Married 2430 (50)

Currently employed 2255 (46)

Current smoker 1689 (35)

Reported history of injection drug use from survey 2456 (52)

Ever received HCV treatment 2404 (49)

Presence of decompensated liver disease22 1169 (24)

Charleson comorbidity score23 ≥ 2 (omitting liver disease) 743 (15)